Saratov JOURNAL of Medical and Scientific Research

Optimization of the diagnosis of cardiovascular autonomic neuropathy in diabetes mellitusand metabolic syndrome

Year: 2021, volume 17 Issue: №1 Pages: 127-131
Heading: Тhematic supplement Article type: Original article
Authors: Moshkhoeva L.S., Barinov A.N.
Organization: First Moscow State Medical University n.a. I.M. Sechenov

Purpose: to clarify and compare the effectiveness of the method of quantitative autonomic testing on the Case-4 apparatus and cardiovascular functional tests performed by pulse oximetry for the early diagnosis of cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and metabolic syndrome. Material and Methods. The study included 30 patients with type 2 diabetes (average age 56.5±13.5 years), 30 patients with metabolic syndrome (average age61±9 years) and 30 healthy subjects (average age 58±10 years), comparable in gender and age with the study groups. The main cardiovascular reflex tests were performed: subjective sensations were assessed using the NSC questionnaire, the severity of deficient neuropathic disorders was assessed by the NIS-LL scale, and neuropathic pain syndrome was assessed by the TSS scale. Results. In the study group of patients with type 2 diabetes, severe cardiac autonomic neuropathy (CAN) was detected in 13.3% of patients, moderate in 40% of patients, and in 46.6% of patients, signs of CAN were not detected. In the group of patients with metabolic syndrome, 10% of patients had severe CAN, 10% had moderate, and 80% of patients had no signs of CAN. In the group of healthy volunteers, no disorders of the autonomic nervous system were identified. Conclusion. The results of pulse oximetry tests with deep breathing were comparable to the results of quantitative autonomic testing with the Case-4 apparatus (p<0.001). The use of pulse oximetry is most expedient in terms of time and consumables in comparison with hardware quantitative vegetative testing.

1. Ziegler D, Voss A, Rathmann W, et al. KORA Study Group Increased prevalence of cardiac autonomic dysfunction at different degrees of glucose intolerance in the general population: the KORA S4 survey. Diabetologia 2015; 58 (5): 1118-28.
2. Novosadova MV, Barinov AN. Autonomic neuropathy in diabetes mellitus: clinical manifestations, diagnosis, treatment. Neurology, Neuropsychiatry, Psychosomatics 2011; 2: 1-8.
3. Vinik Al, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope. Diabetes Med 2011; 28 (6): 643-51.
4. Ziegler D. Cardiovascular autonomic neuropathy: clinical manifestations and measurement. Diabetes Rev 1999; 7: 300-15.
5. Ewing DJ. Cardiovascular reflexes and autonomic neuropathy. Clin Sci Mol Med 1978; 55: 321-7.
6. Strokov IA, Novosadova MV, Barinov AN, Yakhno NN. Clinical methods for assessing the severity of diabetic polyneuropathy. Neurological Journal 2000; 5 (5): 14-9.
7. Dyck PJ, Davies JL, Litchy WJ, et al. Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 1997;49:229-39.
8. Ziegler D, Gries FA. Alpha-lipoic acid in the treatment of diabetic peripheral and cardiac autonomic neuropathy. Diabetes 1997 Sep; 46 (suppl 2): S62-6.
9. Ewing DJ, Clarke BF. Diagnosis and management of diabetic autonomic neuropathy. Br Med J 1982; 285: 916-8.
10. Bernardi L, Spallone V, Stevens M, et al. Methods of investigation for cardiac autonomic dysfunction in human research studies. Diabetes Metab Res Rev 2011; 1-21.
11. Kempler P. Autonomic neuropathy: a marker of cardiovascular risk: Review. British Journal of Diabetes & Vascular Disease 2003; 3: 84-90.
12. Sztanek F, Jebelovszki E, Gaszner B, et al. Diagnosis of diabetic cardiac autonomic neuropathy. Orvosi Hetilap 2019; 160 (35): 1366-75.

2021_01-1_127-131.pdf463.76 KB

No votes yet